Advocacy Groups Want Therapeutic Vaccines In New Oncology Office
This article was originally published in The Pink Sheet Daily
Executive Summary
Cancer advocacy groups want FDA to go farther in its plan to consolidate oncology reviews in a single office
You may also be interested in...
Chemo-Preventative Agents Will Move To New Cancer Office In Fall
FDA's Office of Oncology Drug Products will assume responsibility for all chemo-preventative drug reviews beginning in the fall, Office of New Drugs Director John Jenkins, MD, told reporters July 16
FDA Will Conduct "National Search" For Head Of Oncology Office
The agency formally announces creation of an Office of Oncology Drug Products. The new director will oversee the consolidation of three areas within the Center for Drug Evaluation & Research currently responsible for cancer drug reviews.
Chemo-Preventative Agents Will Move To New Cancer Office In Fall
FDA's Office of Oncology Drug Products will assume responsibility for all chemo-preventative drug reviews beginning in the fall, Office of New Drugs Director John Jenkins, MD, told reporters July 16